UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000043078
Receipt No. R000049181
Scientific Title Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients
Date of disclosure of the study information 2021/01/21
Last modified on 2021/01/21 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients
Acronym Mg and BMD on fractures among HD patients
Scientific Title Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients
Scientific Title:Acronym Mg and BMD on fractures among HD patients
Region
Japan

Condition
Condition End-stage renal failure
fragility fractures
Classification by specialty
Nephrology Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess the association of serum magnesium and BMD with the risk of incident fractures in patients undergoing hemodialysis
Basic objectives2 Others
Basic objectives -Others Investigation for the marker which improved the prediction of fractures
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Any type of fragility fractures
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients who had undergone hemodialysis for least 2 months at Masuko Memorial Hospital
Key exclusion criteria Patients undergoing combination therapy with peritoneal dialysis were excluded.
Target sample size 350

Research contact person
Name of lead principal investigator
1st name Mayuko
Middle name
Last name Hori
Organization Masuko Memorial Hospital
Division name Nephrology
Zip code 453-8566
Address Nakamura-ku Nagoya
TEL +81524511307
Email m-hori@masuko.or.jp

Public contact
Name of contact person
1st name Mayuko
Middle name
Last name Hori
Organization Masuko Memorial Hospital
Division name Nephrology
Zip code 453-8566
Address Nakamura-ku Nagoya
TEL +81524511307
Homepage URL
Email m-hori@masuko.or.jp

Sponsor
Institute Masuko Memorial Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Masuko Memorial Hospital
Address 35-28 Takehashi-cho,
Tel +81524511307
Email m-hori@masuko.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 増子記念病院(愛知県)

Other administrative information
Date of disclosure of the study information
2021 Year 01 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 358
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 04 Month 01 Day
Date of IRB
2020 Year 10 Month 29 Day
Anticipated trial start date
2019 Year 04 Month 01 Day
Last follow-up date
2020 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information assess the association of serum magnesium and BMD with the risk of incident fractures and to determine whether the prediction of the risk of fractures in patients undergoing hemodialysis based on the combination of Mg level and lumbar spine BMD is more accurate than the prediction based on either variable alone

Management information
Registered date
2021 Year 01 Month 21 Day
Last modified on
2021 Year 01 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049181